Theriva Biologics Files S-1/A Amendment

Ticker: TOVX · Form: S-1/A · Filed: Mar 21, 2025 · CIK: 894158

Theriva Biologics, Inc. S-1/A Filing Summary
FieldDetail
CompanyTheriva Biologics, Inc. (TOVX)
Form TypeS-1/A
Filed DateMar 21, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, registration, amendment

TL;DR

Theriva Biologics (formerly Synthetic Biologics) filed an S-1/A amendment on 3/21/25. SEC filing.

AI Summary

Theriva Biologics, Inc. filed an S-1/A amendment on March 21, 2025, for its registration statement. The company, formerly known as Synthetic Biologics, Inc., is incorporated in Nevada and headquartered in Rockville, MD. This filing relates to the Securities Act of 1933.

Why It Matters

This filing indicates Theriva Biologics is actively pursuing regulatory steps for its securities, which could impact its ability to raise capital and its future stock performance.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with capital raises or significant corporate actions, which inherently carry financial and market risks.

Key Numbers

  • 333-283722 — SEC File Number (Identifies this specific registration)
  • 25760976 — Film Number (Internal SEC processing number)

Key Players & Entities

  • Theriva Biologics, Inc. (company) — Registrant
  • Synthetic Biologics, Inc. (company) — Former company name
  • March 21, 2025 (date) — Filing date
  • Steven A. Shallcross (person) — CEO and CFO
  • Nevada (jurisdiction) — State of incorporation
  • Rockville, MD (location) — Principal executive offices

FAQ

What is the purpose of this S-1/A filing?

This is an amendment to a registration statement filed under the Securities Act of 1933, indicating ongoing efforts related to securities registration.

When was this amendment filed?

The amendment was filed on March 21, 2025.

What was Theriva Biologics, Inc. previously named?

Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc.

Where is Theriva Biologics, Inc. headquartered?

The company's principal executive offices are located at 9605 Medical Center, Suite 270, Rockville, MD 20850.

In which state is Theriva Biologics, Inc. incorporated?

The company is incorporated in Nevada.

Filing Details

This Form S-1/A (Form S-1/A) was filed with the SEC on March 21, 2025 by Steven A. Shallcross regarding Theriva Biologics, Inc. (TOVX).

View full filing on EDGAR

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.